Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006–2017

Enterovirus A71 (EV-A71) and coxsackievirus A6 (CVA6) cause hand, foot and mouth disease (HFMD) and are occasionally linked to severe neurologic complications and large outbreaks worldwide. We estimated EV-A71 and CVA6 seroprevalence using cross-sectional age-stratified samples collected in 2006, 2011, and 2017. Seroprevalences of EV-A71 and CVA6 increased from 32% and 54% at 6–11 months to >75% by 10 years of age. Antibody titers declined after 20 years, which could indicate infrequent re-exposure in older populations. Age profiles for acquiring infections and mean titers were comparable in the 3 testing years, despite the marked increase in incidence of CVA6-related HFMD from 2010. The uncoupling of changes in disease severity from the infection kinetics of CVA6 as we inferred from the seroprevalence data, rather than incidence of infection over the 11-year study period, provides further evidence for a change in its pathogenicity.

[1]  J. Bray,et al.  Evolution of Sequence Type 4821 Clonal Complex Hyperinvasive and Quinolone-Resistant Meningococci , 2021, Emerging infectious diseases.

[2]  P. Turner,et al.  Improving Treatment and Outcomes for Melioidosis in Children, Northern Cambodia, 2009–2018 , 2021, Emerging infectious diseases.

[3]  M. Szabó,et al.  Genomic Analysis of Novel Poxvirus Brazilian Porcupinepox Virus, Brazil, 2019 , 2021, Emerging infectious diseases.

[4]  D. Timmermans,et al.  Dynamic Public Perceptions of the Coronavirus Disease Crisis, the Netherlands, 2020 , 2021, Emerging infectious diseases.

[5]  Hoang Minh Tu Van,et al.  Neutralizing Antibodies against Enteroviruses in Patients with Hand, Foot and Mouth Disease , 2020, Emerging infectious diseases.

[6]  P. Simmonds,et al.  Circulation of non-polio enteroviruses in 24 EU and EEA countries between 2015 and 2017: a retrospective surveillance study. , 2019, The Lancet. Infectious diseases.

[7]  S. Gau,et al.  Enterovirus A71 neurologic complications and long-term sequelae , 2019, Journal of Biomedical Science.

[8]  D. Boutolleau,et al.  Multirecombinant Enterovirus A71 Subgenogroup C1 Isolates Associated with Neurologic Disease, France, 2016–2017 , 2019, Emerging infectious diseases.

[9]  P. Horby,et al.  Increase in Enterovirus D68 Infections in Young Children, United Kingdom, 2006–2016 , 2019, Emerging infectious diseases.

[10]  N. Grassly,et al.  Serotype-specific immunity explains the incidence of diseases caused by human enteroviruses , 2018, Science.

[11]  Hoang Minh Tu Van,et al.  Emerging Coxsackievirus A6 Causing Hand, Foot and Mouth Disease, Vietnam , 2018, Emerging infectious diseases.

[12]  P. Horby,et al.  Recommendations for enterovirus diagnostics and characterisation within and beyond Europe. , 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[13]  C. Ortez,et al.  Outbreak of brainstem encephalitis associated with enterovirus-A71 in Catalonia, Spain (2016): a clinical observational study in a children's reference centre in Catalonia. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  D. Levy-bruhl,et al.  Severe paediatric conditions linked with EV-A71 and EV-D68, France, May to October 2016 , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[15]  H. Mentzel,et al.  A severe pediatric infection with a novel enterovirus A71 strain, Thuringia, Germany. , 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[16]  M. D. de Jong,et al.  Emerging Blockininfectious Blockindiseases Blockin@bullet Blockin Prediction of Protection against Asian Enterovirus 71 Outbreak Strains by Cross-neutralizing Capacity of Serum from Dutch Donors, the Netherlands , 2022 .

[17]  D. Hober,et al.  Hand, foot and mouth disease (HFMD): emerging epidemiology and the need for a vaccine strategy , 2016, Medical Microbiology and Immunology.

[18]  E. Lau,et al.  Seroprevalence of Enterovirus 71 Antibody Among Children in China: A Systematic Review and Meta-analysis , 2015, The Pediatric infectious disease journal.

[19]  S. Diedrich,et al.  Transmission patterns of human enterovirus 71 to, from and among European countries, 2003 to 2013. , 2015, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[20]  Zhenglun Liang,et al.  Coxsackievirus A6: a new emerging pathogen causing hand, foot and mouth disease outbreaks worldwide , 2015, Expert review of anti-infective therapy.

[21]  P. Chong,et al.  Is a multivalent hand, foot, and mouth disease vaccine feasible? , 2015, Human vaccines & immunotherapeutics.

[22]  K. Goh,et al.  Seroepidemiology of Coxsackievirus A6, Coxsackievirus A16, and Enterovirus 71 Infections among Children and Adolescents in Singapore, 2008-2010 , 2015, PloS one.

[23]  P. Simmonds,et al.  Genetic characterization of human coxsackievirus A6 variants associated with atypical hand, foot and mouth disease: a potential role of recombination in emergence and pathogenicity , 2015, The Journal of general virology.

[24]  R. Pebody,et al.  Enterovirus infections in England and Wales, 2000-2011: the impact of increased molecular diagnostics. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[25]  C. Lee,et al.  Atypical hand, foot, and mouth disease: eczema coxsackium can also occur in adults. , 2014, The Lancet. Infectious diseases.

[26]  J. Modlin,et al.  Atypical hand, foot, and mouth disease: a vesiculobullous eruption caused by Coxsackie virus A6 , 2014, BDJ.

[27]  Cécile Viboud,et al.  Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. , 2014, The Lancet. Infectious diseases.

[28]  P. Simmonds,et al.  Atypical hand, foot, and mouth disease associated with coxsackievirus A6 infection, Edinburgh, United Kingdom, January to February 2014. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[29]  B. King,et al.  Atypical Hand-Foot-Mouth Disease Associated with Coxsackievirus A6 Infection , 2018 .

[30]  C. Ginocchio,et al.  “Eczema Coxsackium” and Unusual Cutaneous Findings in an Enterovirus Outbreak , 2013, Pediatrics.

[31]  K. Tsao,et al.  Comparative Genomic Analysis of Coxsackievirus A6 Strains of Different Clinical Disease Entities , 2012, PloS one.

[32]  J. Farrar,et al.  The Seroprevalence and Seroincidence of Enterovirus71 Infection in Infants and Children in Ho Chi Minh City, Viet Nam , 2011, PloS one.

[33]  Tom Solomon,et al.  Virology, epidemiology, pathogenesis, and control of enterovirus 71. , 2010, The Lancet. Infectious diseases.

[34]  H. Doerr,et al.  Hand, foot and mouth disease: seroprevalence of Coxsackie A16 and Enterovirus 71 in Germany , 2010, Medical Microbiology and Immunology.

[35]  T. Hyypiä,et al.  Coxsackievirus A6 and Hand, Foot, and Mouth Disease, Finland , 2009, Emerging infectious diseases.

[36]  S. Diedrich,et al.  Seroprevalence and molecular epidemiology of enterovirus 71 in Germany , 2009, Archives of Virology.

[37]  Tzou-Yien Lin,et al.  Enterovirus 71 maternal antibodies in infants, Taiwan. , 2009, Emerging infectious diseases.

[38]  Kow-Tong Chen,et al.  An eight-year study of epidemiologic features of enterovirus 71 infection in Taiwan. , 2007, The American journal of tropical medicine and hygiene.

[39]  R. Marttila,et al.  Diagnosis of enteroviral meningitis by use of polymerase chain reaction of cerebrospinal fluid, stool, and serum specimens. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  E. Ooi,et al.  Seroepidemiology of Human Enterovirus 71, Singapore , 2002, Emerging infectious diseases.